文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

慢性阻塞性肺疾病急性加重接受无创通气的患者ICU使用情况

ICU Utilization for Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Noninvasive Ventilation.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论回顾性队列显示,COPD急性加重接受无创通气的患者在不同ICU使用率医院住院死亡率相似,低ICU使用率医院有创监测更少、费用可能更低,作者主张医院改变无创通气策略前应进行医院特异性风险评估。

该回顾性队列研究利用2014年州住院患者数据库,纳入12个州424家医院5081例≥18岁、主要诊断COPD急性加重、次要诊断呼吸衰竭并接受无创通气的住院患者,探讨在ICU外安全实施无创通气的可能性。医院层面ICU使用率范围为0.05至0.98,总体中位住院死亡率为2.62%(四分位距1.72-3.88%)。多水平logistic回归显示ICU使用率与住院死亡率(β=0.01;p=0.05)或住院时长(β=0.18;p=0.41)无显著关联,Spearman相关分析证实(ρ=0.06;p=0.20和ρ=0.02;p=0.64)。较低ICU使用率与较低有创监测置入率相关(线性回归β=0.05;p<0.001;Spearman ρ=0.28;p<0.001),线性回归显示较低ICU使用率与显著较低费用相关(β=14.91;p=0.02),但Spearman相关未达显著(ρ=0.09;p=0.07)。作者认为结果提示无创通气可在ICU外安全实施,但医院改变无创通气策略前应进行医院特异性风险评估。

要点

  • 在5081例COPD急性加重接受无创通气的住院患者中,医院ICU使用率范围0.05-0.98,总体中位住院死亡率2.62%(IQR 1.72-3.88%)。
  • ICU使用率与住院死亡率无显著关联(β=0.01;p=0.05),Spearman相关分析证实(ρ=0.06;p=0.20)。
  • 较低ICU使用率与较低有创监测置入率相关(线性回归β=0.05;p<0.001;Spearman ρ=0.28;p<0.001)。
  • 线性回归显示较低ICU使用率与显著较低费用相关(β=14.91;p=0.02),但Spearman相关未达显著(ρ=0.09;p=0.07)。
  • 作者认为结果提示无创通气可在ICU外安全实施,但医院改变无创通气策略前应进行医院特异性风险评估。

适用人群与场景

  • 年龄≥18岁、主要诊断为慢性阻塞性肺疾病急性加重、次要诊断为呼吸衰竭并接受无创通气的住院患者。
  • 数据来源为2014年州住院患者数据库中12个州、424家医院,患者来自住院场景,非急诊或院前场景。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入12个州424家医院5081例住院患者,无干预。
  • 主要终点为住院死亡率,总体中位住院死亡率为2.62%(IQR 1.72-3.88%);医院ICU使用率范围为0.05至0.98。
  • ICU使用率与住院死亡率无显著关联(β=0.01;p=0.05),Spearman相关分析证实(ρ=0.06;p=0.20)。
  • ICU使用率与住院时长无显著关联(β=0.18;p=0.41),Spearman相关分析证实(ρ=0.02;p=0.64)。
  • 较低ICU使用率与较低有创监测置入率相关(线性回归β=0.05;p<0.001;Spearman ρ=0.28;p<0.001)。
  • 较低ICU使用率与显著较低费用相关(线性回归β=14.91;p=0.02),但Spearman相关未达显著(ρ=0.09;p=0.07)。

证据类型、等级与局限

  • 证据类型为回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,结果提示无创通气可在ICU外安全实施。
  • 作者主张,医院若考虑改变无创通气实施策略,应进行医院特异性风险评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: We investigated whether patients with chronic obstructive pulmonary disease could safely receive noninvasive ventilation outside of the ICU.

DESIGN: Retrospective cohort study.

SETTING: Twelve states with ICU utilization flag from the State Inpatient Database from 2014.

PATIENTS: Patients greater than or equal to 18 years old with primary diagnosis of acute exacerbation of chronic obstructive pulmonary disease and secondary diagnosis of respiratory failure who received noninvasive ventilation.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Multilevel logistic regression models were used to obtain hospital-level ICU utilization rates. We risk-adjusted using both patient/hospital characteristics. The primary outcome was in-hospital mortality; secondary outcomes were invasive monitoring (arterial/central catheters), hospital length of stay, and cost. We examined 5,081 hospitalizations from 424 hospitals with ICU utilization ranging from 0.05 to 0.98. The overall median in-hospital mortality was 2.62% (interquartile range, 1.72-3.88%). ICU utilization was not significantly associated with in-hospital mortality (β = 0.01; p = 0.05) or length of stay (β = 0.18; p = 0.41), which was confirmed by Spearman correlation (ρ = 0.06; p = 0.20 and ρ = 0.02; p = 0.64, respectively). However, lower ICU utilization was associated with lower rates of invasive monitor placement by linear regression (β = 0.05; p < 0.001) and Spearman correlation (ρ = 0.28; p < 0.001). Lower ICU utilization was also associated with significantly lower cost by linear regression (β = 14.91; p = 0.02) but not by Spearman correlation (ρ = 0.09; p = 0.07).

CONCLUSIONS: There is wide variability in the rate of ICU utilization for noninvasive ventilation across hospitals. Chronic obstructive pulmonary disease patients receiving noninvasive ventilation had similar in-hospital mortality across the ICU utilization spectrum but a lower rate of receiving invasive monitors and probably lower cost when treated in lower ICU-utilizing hospitals. Although the results suggest that noninvasive ventilation can be delivered safely outside of the ICU, we advocate for hospital-specific risk assessment if a hospital were considering changing its noninvasive ventilation delivery policy.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Myers LC, Faridi MK, Currier P, et al. ICU Utilization for Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Noninvasive Ventilation. Crit Care Med. 2019. PMID: 30720540. doi:10.1097/CCM.0000000000003660

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。